You just read:

North Dallas Research Associates and Cardiac Center of Texas Begin Enrollment in TOBA II BTK Clinical Trial for New Peripheral Revascularization Treatment Option

News provided by

North Dallas Research Associates

02 Mar, 2017, 13:30 ET